These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 32622200

  • 21. Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.
    Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O.
    J Viral Hepat; 2015 Apr; 22(4):427-32. PubMed ID: 25181653
    [Abstract] [Full Text] [Related]

  • 22. No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
    Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal MA, Møller HJ, Bendtsen F, Grønbæk H.
    PLoS One; 2018 Apr; 13(9):e0203200. PubMed ID: 30183743
    [Abstract] [Full Text] [Related]

  • 23. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T.
    Ann Am Thorac Soc; 2017 Jan; 14(1):57-64. PubMed ID: 27684274
    [Abstract] [Full Text] [Related]

  • 24. The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease.
    Kazankov K, Barrera F, Møller HJ, Rosso C, Bugianesi E, David E, Younes R, Esmaili S, Eslam M, McLeod D, Bibby BM, Vilstrup H, George J, Grønbaek H.
    Liver Int; 2016 Oct; 36(10):1549-57. PubMed ID: 27102725
    [Abstract] [Full Text] [Related]

  • 25. Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
    Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M.
    Liver Int; 2016 Nov; 36(11):1628-1638. PubMed ID: 27031405
    [Abstract] [Full Text] [Related]

  • 26. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, Fujita H, Asano Y, Tada Y, Kadono T, Okochi H, Sato S.
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [Abstract] [Full Text] [Related]

  • 27. Associations of Serological Biomarkers of sICAM-1, IL-1β, MIF, and su-PAR with 3-Month Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Li X, Zhou Y, Zou R, Chen H, Liu X, Qiu X, Xiao Y, Cai H, Dai J.
    Mediators Inflamm; 2020 Oct; 2020():4534272. PubMed ID: 32694925
    [Abstract] [Full Text] [Related]

  • 28. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
    Hanaka T, Kido T, Noguchi S, Yamada S, Noguchi H, Guo X, Nawata A, Wang KY, Oda K, Takaki T, Izumi H, Ishimoto H, Yatera K, Mukae H.
    BMC Pulm Med; 2019 Dec 30; 19(1):265. PubMed ID: 31888585
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF).
    Grønbæk H, Rødgaard-Hansen S, Aagaard NK, Arroyo V, Moestrup SK, Garcia E, Solà E, Domenicali M, Piano S, Vilstrup H, Møller HJ, CANONIC study investigators of the EASL-CLIF Consortium.
    J Hepatol; 2016 Apr 30; 64(4):813-22. PubMed ID: 26639396
    [Abstract] [Full Text] [Related]

  • 31. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, Horie T, Takise A, Hisada T.
    Medicina (Kaunas); 2019 May 13; 55(5):. PubMed ID: 31086028
    [Abstract] [Full Text] [Related]

  • 32. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
    Semnani-Azad Z, Connelly PW, Johnston LW, Retnakaran R, Harris SB, Zinman B, Hanley AJ.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):e285-94. PubMed ID: 31677389
    [Abstract] [Full Text] [Related]

  • 33. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.
    Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926
    [Abstract] [Full Text] [Related]

  • 34. Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis.
    Min H, Fan S, Song S, Zhuang Y, Li H, Wu Y, Cai H, Yi L, Dai J, Gao Q.
    Diagn Pathol; 2016 Nov 23; 11(1):135. PubMed ID: 27881157
    [Abstract] [Full Text] [Related]

  • 35. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 23; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 36. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.
    Arthritis Rheum; 2007 Mar 23; 56(3):965-71. PubMed ID: 17328073
    [Abstract] [Full Text] [Related]

  • 37. The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT.
    De Vlieger G, Vanhorebeek I, Wouters PJ, Derese I, Casaer MP, Debaveye Y, Hermans G, Meersseman P, Møller HJ, Van den Berghe G, Ingels C.
    Crit Care; 2019 Aug 02; 23(1):270. PubMed ID: 31375142
    [Abstract] [Full Text] [Related]

  • 38. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D, Yao Y, Yang C, Zhang S.
    Cancer Biomark; 2018 Feb 14; 21(3):689-700. PubMed ID: 29226859
    [Abstract] [Full Text] [Related]

  • 39. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.
    PLoS One; 2015 Feb 14; 10(4):e0119681. PubMed ID: 25860354
    [Abstract] [Full Text] [Related]

  • 40. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
    Kazankov K, Barrera F, Møller HJ, Bibby BM, Vilstrup H, George J, Grønbaek H.
    Hepatology; 2014 Aug 14; 60(2):521-30. PubMed ID: 24623375
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.